IRIS PubliCatt

Lucchini, Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.413
EU - Europa 1.266
AS - Asia 448
AF - Africa 32
OC - Oceania 7
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.175
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.401
DE - Germania 356
SE - Svezia 341
IT - Italia 210
SG - Singapore 171
CN - Cina 144
IE - Irlanda 94
FR - Francia 64
ID - Indonesia 63
GB - Regno Unito 41
UA - Ucraina 40
IN - India 35
RU - Federazione Russa 34
CI - Costa d'Avorio 26
FI - Finlandia 20
BE - Belgio 10
PL - Polonia 10
NL - Olanda 8
TR - Turchia 8
CA - Canada 7
BR - Brasile 6
RO - Romania 6
IR - Iran 5
AU - Australia 4
ES - Italia 4
IL - Israele 4
JP - Giappone 4
CH - Svizzera 3
CU - Cuba 3
DK - Danimarca 3
KR - Corea 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
HU - Ungheria 2
IQ - Iraq 2
LT - Lituania 2
MK - Macedonia 2
MX - Messico 2
NO - Norvegia 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
AT - Austria 1
BN - Brunei Darussalam 1
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
KE - Kenya 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MT - Malta 1
NP - Nepal 1
SC - Seychelles 1
TH - Thailandia 1
VN - Vietnam 1
Totale 3.175
Salva come PNG Salva come JPEG
Città #
Chandler 418
Ashburn 140
Singapore 127
Dublin 94
New York 70
Jakarta 63
San Mateo 55
Princeton 37
Rome 37
Wilmington 37
Beijing 36
Boston 35
Nürnberg 30
Abidjan 26
Ann Arbor 25
Moscow 25
Milan 22
Redmond 22
Chicago 21
Los Angeles 19
Jacksonville 18
Nanjing 18
Cattolica 17
Seattle 16
Fairfield 15
Pune 14
Marseille 13
Bremen 12
Munich 12
Helsinki 10
Norwalk 10
London 9
Brussels 8
Houston 8
Lawrence 8
Woodbridge 8
Dearborn 7
Florence 7
Redwood City 7
Andover 6
Leawood 6
Paris 6
Bari 5
Boardman 5
Hyderabad 5
Izmir 5
Lviv 5
Mountain View 5
Warsaw 5
Avon 4
Catania 4
Edinburgh 4
Jiaxing 4
Nanchang 4
Shenyang 4
São Paulo 4
Toronto 4
Washington 4
Amsterdam 3
Augusta 3
Berlin 3
Brentonico 3
Busto Arsizio 3
Cambridge 3
Chiswick 3
Cologno Al Serio 3
Falls Church 3
Fuzhou 3
Guangzhou 3
Gunzenhausen 3
Havana 3
Hebei 3
Istanbul 3
Kish 3
Nibionno 3
Phoenix 3
Saint Louis 3
Seoul 3
Septeme 3
Zurich 3
Ansbach 2
Atlanta 2
Baotou 2
Bologna 2
Bucharest 2
Budapest 2
Buffalo 2
Caldaro sulla Strada del Vino 2
Capua 2
Cerro Maggiore 2
Changchun 2
Changsha 2
Chiavari 2
Clearwater 2
Denno 2
Erbil 2
Frankfurt am Main 2
Fremont 2
Hamilton 2
Hounslow 2
Totale 1.751
Salva come PNG Salva come JPEG
Nome #
Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis 263
Primary fibroblasts cultures reveal TDP-43 abnormalities in amyotrophic lateral sclerosis patients with and without SOD1 mutations 191
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 101
Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis 91
Predictors of lymphocyte count recovery after dimethyl fumarate-induced lymphopenia in people with multiple sclerosis 85
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 79
Oculopharyngeal muscular dystrophy: Clinical and neurophysiological features 73
Fingolimod vs dimethyl fumarate in multiple sclerosis 72
Long-term Follow-up and Muscle Imaging Findings in Brachio-Cervical Inflammatory Myopathy 71
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 68
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients 68
A TLR/CD44 axis regulates T cell trafficking in experimental and human multiple sclerosis 68
Novel SEC61G-EGFR fusion gene in pediatric ependymomas discovered by clonal expansion of stem cells in absence of exogenous mitogens 66
Dominus effect: challenging complications of alemtuzumab-related thyroid autoimmunity 66
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. 65
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 65
Prognostic factors after treatment for iterative thymoma recurrences: A multicentric experience 64
Lower urinary tract disorders in multiple sclerosis patients: prevalence, clinical features, and response to treatments 61
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 57
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 57
A unique case of multiphasic ADEM or what else? 54
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study 53
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment 52
Upper body involvement in GNE myopathy assessed by muscle imaging 52
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review 51
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients 50
Long-term Follow-up and Muscle Imaging Findings in Brachio-Cervical Inflammatory Myopathy 50
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 49
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study 49
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 48
Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis 48
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre 48
New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report 47
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 47
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 46
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 46
Ixekizumab exposure associated with myelitis: A case report and a literature review 46
Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies 45
Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosis 44
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 44
Shift of multiple sclerosis onset towards older age 44
Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of myasthenia-myositis association from a large cohort of patients 43
Cyclophosphamide in highly aggressive Marburg-like multiple sclerosis 43
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report 40
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 40
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 38
Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach 29
Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis 27
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 26
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis 24
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 24
Signs and symptoms of COVID-19 in patients with multiple sclerosis 20
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 19
Serum-Circulating microRNAs in Sporadic Inclusion Body Myositis 17
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 17
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy 17
Current Status of Oral Disease-Modifying Treatment Effects on Cognitive Outcomes in Multiple Sclerosis: A Scoping Review 17
COVID-19 presenting as a non-arteritic anterior ischemic optic neuropathy 15
Tumefactive Demyelinating Lesion Around a Developmental Venous Anomaly: A Rare Association 15
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab 14
Assessing treatment response to oral drugs for multiple sclerosis in real-world setting: a MAGNIMS Study 13
New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report 12
Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant? 9
Totale 3.263
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.994
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020163 0 0 0 0 15 15 17 11 20 36 40 9
2020/2021168 7 9 1 11 13 6 9 18 15 24 40 15
2021/2022476 42 19 8 61 8 15 6 76 32 26 78 105
2022/20231.111 131 139 77 167 69 136 57 104 140 25 46 20
2023/2024630 23 146 26 37 16 110 44 52 10 21 68 77
2024/2025292 29 37 109 63 54 0 0 0 0 0 0 0
Totale 3.263